Global Market Study on RNA-Based Therapeutics and Vaccines: Post Covid-era to Bolster Extensive Research Pertaining to RNA-based Therapeutics and Vaccines

May 2022| PMR940B| Persistence Market Research

Report Highlights

RNA-Based Therapeutics and Vaccines Market Analysis 2022-2028

A recent market study published by Persistence Market Research (PMR) on the RNA-Based Therapeutics and Vaccines Market including global industry analysis for 2013-2021 & opportunity assessment for 2022-2028, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.

RNA-Based Therapeutics and Vaccines Market: Segmentation

The global RNA-Based Therapeutics and Vaccines Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • Workstations
  • Reagents and Consumables
  • Kits (RNA sample preparation and DNA sample preparation)

Application

  • Research Applications
  • Diagnostic Testing
  • Clinical Testing

End User

  • Diagnostic Centers
  • Hospitals
  • Academic & Research Institutes
  • Forensic Science Laboratories
  • CROs (Contract Research Organizations)

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Key Questions Answered in Report

The research study offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

  • What are the key trends that are continuously shaping market growth?
  • Which are the prominent regions that offer plentiful opportunities for players in the market?
  • How has the outbreak of COVID-19 affected the market and what would the trend be like during the forecast period?
  • What are the differential strategies adopted by key players to hold a significant share in the RNA-Based Therapeutics and Vaccines industry?

Frequently Asked Questions (FAQs)

Research Methodology

A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.

The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.

The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Alnylam Pharmaceuticals, Inc., Arbutus Biopharma Corp., Arrowhead Pharmaceuticals, Inc., BioNTech AG, CureVac AG, Dicerna Pharmaceuticals, Inc., and Regulus Therapeutics, Inc., among others.

  • Table 1 : Expenditure on Health, (% of GDP), by Country, 2013 - 2021
  • Table 2 : North America RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Country
  • Table 3 : North America RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Product Type
  • Table 4 : North America RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Indication
  • Table 5 : Latin America RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Product Type
  • Table 6 : Latin America RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Indication
  • Table 7 : Europe RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Country
  • Table 8 : Europe RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Product Type
  • Table 9 : Europe RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Indication
  • Table 10 : Asia Pacific RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Country
  • Table 11 : Asia Pacific RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Product Type
  • Table 12 : Asia Pacific RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Indication
  • Table 13 : Middle East & Africa RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment 2022-2028, By Product Type
  • Table 14 : Middle East & Africa RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment 2022-2028, By Indication
  • Table 15 : Competitive Scenario for Hereditary ATTR Amyloidosis (Patisiran (ALN-TTR02))
  • Table 16 : Competitive Scenario for Hemophilia A Fitusiran (ALN-AT3SC)
  • Table 17 : Competitive Scenario for Hypercholesterolemia (Inclisiran)
  • Table 18 : Global RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment 2022-2028, By Region
  • Table 19 : Global RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment, 2022-2028, By Product Type
  • Table 20 : Global RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis & Opportunity Assessment 2022-2028, By Indication
  • Figure 1 : Estimated/Actual launching of RNA Therapeutics and Vaccines and their Impact on market
  • Figure 2 : Global RNA based Vaccines Pipeline Assessment: By Development Phase
  • Figure 3 : Global RNA based Vaccines Pipeline Assessment: By Disease Indication
  • Figure 4 : Global RNA based Therapeutics Pipeline Assessment: By Development Phase
  • Figure 5 : Global RNA based Therapeutics Pipeline Assessment
  • Figure 6 : North America RNA-based Therapeutics and Vaccines Market Share, By Country (2022)
  • Figure 7 : North America RNA-based Therapeutics and Vaccines Market size (US$ Mn) 2022 & 2028
  • Figure 8 : North America RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis, 2022-2028
  • Figure 9 : Latin America RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis, 2022-2028
  • Figure 10 : Europe RNA-based Therapeutics and Vaccines Market Share, By Country (2022)
  • Figure 11 : Europe RNA-based Therapeutics and Vaccines Market size (US$ Mn) 2022 & 2028
  • Figure 12 : Europe RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis, 2022-2028
  • Figure 13 : Asia Pacific RNA-based Therapeutics and Vaccines Market Share, By Country (2022)
  • Figure 14 : Asia Pacific RNA-based Therapeutics and Vaccines Market size (US$ Mn) 2022 & 2028
  • Figure 15 : Asia Pacific RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis, 2022-2028
  • Figure 16 : Middle East & Africa RNA-based Therapeutics and Vaccines Market Size (US$ Mn) Analysis, 2022-2028
  • Figure 17 : Global RNA-based Therapeutics and Vaccines Market Share, By Region (2028)
  • Figure 18 : Global RNA-based Therapeutics and Vaccines Market size (US$ Mn) 2022 & 2028, By Region
  • Figure 19 : Global RNA-based Therapeutics and Vaccines Market Share, By Product Type (2028)
  • Figure 20 : Global RNA-based Therapeutics and Vaccines Market Share, By RNA-based Therapeutics segment (2028)
  • Figure 21 : Global RNA-based Therapeutics and Vaccines Market Share, By Indication (2028)
  • Figure 22 : Global RNA-based Therapeutics and Vaccines Market Value Analysis and Opportunity Assessment, 2022-2028 (US$ Mn)
  • Figure 23 : Global RNA-based Therapeutics and Vaccines Market Absolute $ Opportunity (US$ Mn), 2022-2028

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Similar Reports from Persistence Market Research

Global Opportunity Assessment of RNA-based Therapeutics and Vaccines

  • Date - Aug 2018
  • Code - PMR940A

This Persistence Market Research (PMR) report examines the ‘Global RNA-based Therapeutics and Vaccines Market for the period 2019–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global RNA-based Therapeutics and Vaccines Market.

The RNA-based Therapeutics and Vaccines Market is Segmented as Follows:

RNA-based Therapeutics and Vaccines Market, by ...

Persistence Market Research
Price: $4900

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.